US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
PhaseBio Pharmaceuticals Inc (PHAS)
PhaseBio Pharmaceuticals Inc (PHAS) ニュース

PHAS

PhaseBio Pharmaceuticals (PHAS)

PhaseBio Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PHAS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/05/31	05 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2023/05/20	05 : 19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2023/05/20	05 : 19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2023/05/20	05 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2023/05/20	05 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2023/05/17	05 : 23	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2023/04/04	05 : 06	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2023/03/24	21 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2023/02/15	07 : 07	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2023/02/15	05 : 01	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2023/02/15	04 : 27	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/12/23	22 : 34	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/12/21	20 : 10	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/12/03	06 : 20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/11/16	06 : 21	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/11/05	05 : 44	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/11/01	06 : 22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/10/27	05 : 42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/10/24	21 : 00	Business Wire	PhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy Code	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/10/08	06 : 22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/09/29	01 : 05	TipRanks	Phasebio Pharmaceuticals (PHAS) was downgraded to a Hold Rating at Needham	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/09/28	06 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/08/15	19 : 15	TipRanks	H.C. Wainwright Keeps Their Buy Rating on Phasebio Pharmaceuticals (PHAS)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/08/13	05 : 15	TipRanks	Phasebio Pharmaceuticals (PHAS) Receives a Buy from Needham	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/08/12	21 : 34	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/08/12	21 : 30	Business Wire	PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/07/06	05 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/06/16	21 : 18	TipRanks	10 Penny Stocks that Could Deliver Exponential Returns	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/05/25	06 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc
2022/05/25	06 : 14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PHAS	PhaseBio Pharmaceuticals Inc

Showing the most relevant articles for your search:NASDAQ:PHAS

1 2 3 4 5 6 7 8 9 10 次へ >>

Gold vs US Dollar

JP Morgan Chase

BNP Paribas (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約